Topic: Region - Africa

In this study, we explore how intent to receive a COVID-19 vaccine evolved in Nigeria (both nationally and sub-nationally) between March 2021 (when the first vaccines were administered to healthcare workers) and October 2021.

Between October 31, 2020 and December 15, 2020, 26,759 individuals were surveyed across 32 countries via nationally representative survey designs.

Overview The Vaccine Confidence Project at the London School of Hygiene & Tropical Medicine, in partnership with Premise, developed ASSURE – Assessing Signals and Supporting Resilience.

Dr. Abosede Lewu from Girlsaid Initiative describes his experience with HPV vaccine advocacy and…

Dr. Omolola Salako shares her experience with HPV vaccination in Nigeria.

Ishak Lawal from End Cervical Cancer Nigeria Initiative shares lessons learned from a HPV pilot demonstration in Nigeria.

Bassey Okposen from the National Primary Health Care Development Agency in Nigeria shares the process and the challenges being faced to…

Kouassi Seraphin, Oumar Toure, and Chris Morgan from Jhpiego share the impact the COVID-19 pandemic has…

Ngwegwe Bulula provides an overview of the HPV demonstration project and the progress made toward national introduction in Tanzania.

Dr. Raphael Kyalakishaija Nshunju describes the successful organisation of advocacy, communication, and social mobilisation for HPV vaccine introduction in…

It is an incredible scientific and collective achievement that we have not just one vaccine against COVID-19, but multiple…

The aim of this study was to investigate public knowledge and perceptions of both the COVID-19 pandemic itself and COVID-19 vaccine acceptance among adults (aged…